Tilur

Quick links to important sections

Tilur

Treatment option:

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Tilur

Quick Facts

Property Description
Active ingredient Acemetacin (a prodrug of Indomethacin)
Form Hard capsules, Rectal suppositories
Pharmacological class Non-Steroidal Anti-Inflammatory Drug (NSAID)
General purpose Symptomatic management of pain and inflammation
Origin Synthetic indole derivative

Tilur: A Non-Steroidal Anti-Inflammatory Drug (NSAID)

Tilur is a prescription-only medicine chemically classified as a Non-Steroidal Anti-Inflammatory Drug (NSAID), used for the systemic relief of pain and inflammation. It is a single-ingredient preparation containing the active substance Acemetacin, a compound designed for absorption into the body. The medication belongs to the indole derivative subgroup of NSAIDs, underscoring its foundation in a specific class of synthetic chemical structures developed to combat the body's inflammatory response. Tilur is available in multiple forms: hard capsules for the oral route and rectal suppositories, allowing for flexible systemic administration.


What is the Active Ingredient Acemetacin?

The therapeutic efficacy of Tilur is provided by its active pharmaceutical ingredient, Acemetacin, a synthetic molecule. Acemetacin is structurally related to the NSAID Indomethacin and functions as a prodrug, meaning it is metabolized within the body into Indomethacin to achieve its primary effects. The mechanism of action involves the inhibition of prostaglandin synthesis—the chemical messengers that trigger inflammation, pain transmission, and fever. By disrupting this process, Acemetacin provides three primary effects: anti-inflammatory, analgesic (pain-relieving), and antipyretic (fever-reducing).


General Purpose and Therapeutic Application

The general purpose of Tilur is the symptomatic management of discomfort arising from inflammatory diseases, serving as an anti-rheumatic agent. Its primary role is to provide relief from the swelling and pain associated with chronic or acute musculoskeletal conditions, such as rheumatic diseases and degenerative joint diseases. The medication's dual analgesic and anti-inflammatory profile allows it to target the underlying process of inflammation while simultaneously alleviating the resulting discomfort.

What side effects are possible with Tilur?

Possible Side Effects and Safety Information

The safety profile of Tilur (Acemetacin) reflects its classification as a Non-Steroidal Anti-Inflammatory Drug (NSAID) and is defined by documented adverse reactions categorized by frequency and the body system affected, according to regulatory standards.

Official Frequency-Classified Adverse Reactions

Adverse reactions are formally grouped by System-Organ Class (SOC):

Frequency Category Examples of Affected Systems
Common (1–10%) Gastrointestinal Disorders (e.g., nausea, abdominal pain, dyspepsia), Nervous System Disorders (e.g., headache, dizziness), General Disorders (e.g., edema/fluid retention).
Uncommon/Rare (<1%) Skin and Subcutaneous Tissue Disorders (e.g., rash, pruritus), Hepatobiliary Disorders (e.g., liver enzyme elevations), Hematologic Disorders (e.g., aplastic anemia).

Documented Serious Adverse Reactions

Official labels detail potential rare but serious class effects. These include the risk of serious cardiovascular thrombotic events, such as myocardial infarction and stroke. There is also a documented risk of serious gastrointestinal events, including ulceration, bleeding, and perforation of the stomach or intestines, which may be fatal. Severe skin reactions, such as Stevens-Johnson Syndrome (SJS), are also officially noted.

Safety Considerations and Limitations

Regulatory documents include specific safety constraints and population notes. The risk of serious adverse reactions, particularly gastrointestinal and cardiovascular events, is noted to generally increase with the duration of use.

Tilur is formally restricted or contraindicated in patients with severe conditions, including severe heart failure, severe renal or hepatic impairment, and documented gastrointestinal ulceration or bleeding. Furthermore, official safety notes indicate the medicine is contraindicated during the third trimester of pregnancy due to specific fetal risks.

Overdose and Emergency Response

Overdose and When to Seek Help

Overdose with Tilur is defined in regulatory documents as a serious, potentially fatal event centered on the risk of severe liver damage (hepatotoxicity) that can lead to acute liver failure and death. This risk is primarily linked to ingesting an amount that exceeds the maximum recommended daily dose.

Documented Overdose Profile

Official labeling emphasizes that early overdose symptoms are often non-specific or may be absent during the first 24 hours. Initial manifestations may include only mild gastrointestinal distress, such as nausea, vomiting, pallor, or sweating. These mild signs do not reliably indicate the degree of severe internal injury that may be occurring.

Classification Manifestation/Risk
Severity Serious / Potentially Fatal
Key System Affected Hepatic (Liver Failure)
Treatment Factor Antidote is Time-Critical

Requirement for Emergency Medical Help

Due to the delayed and severe nature of the primary overdose risk, it is mandatory to seek immediate emergency medical help after any known or suspected overdose, regardless of the presence or absence of symptoms. Delaying treatment can significantly reduce the effectiveness of the specific antidote (e.g., N-acetylcysteine), which is a key component of management. The efficacy of the antidote in preventing irreversible liver damage is highly time-dependent, making immediate intervention vital. Individuals with pre-existing liver issues or chronic high alcohol consumption are documented as having an increased risk for severe complications.

Therapeutic Uses of Tilur

What Tilur Treats: Main Uses and Benefits

Tilur is considered relevant for easing symptoms related to physical discomfort. It is commonly used in contexts marked by increased physiological or emotional tension, where symptoms may become overwhelming. The medication is primarily focused on supportive relief in situations where existing symptoms intensify or become more noticeable.

Tilur assists with managing temporary periods of functional strain, addressing symptom groups that cluster into disruptive patterns, and helping to ease the overall symptomatic burden. The types of situations where it is applied include periods of heightened symptoms, episodic or fluctuating manifestations, and instances where symptoms create noticeable interference with daily functioning.

By offering temporary support in symptom stabilization, Tilur contributes to easing the overall symptom load and may help patients cope more steadily with symptom fluctuations. This support may assist with maintaining a sense of stability when symptoms are more noticeable.

Quick Fact: Supportive Relief for Episodic Discomfort Tilur is used for conditions presenting with acute episodes, assisting with functional stability when symptoms suddenly intensify.

Eligibility and Restrictions for Use

Eligibility Scope

Classification Population Status
Allowed Populations Adults (18 years and older) who do not possess any listed contraindications.
Use Not Recommended Children and adolescents (under 18 years), women who are breastfeeding, and women in the first or second trimesters of pregnancy.
Absolute Contraindication Patients with known hypersensitivity to Acemetacin, Indomethacin, or other NSAIDs (including a history of asthma or angioedema induced by these agents).

Eligibility Restrictions and Prohibitions

Use is absolutely prohibited in individuals with active or recurrent peptic ulcer/gastrointestinal hemorrhage (bleeding/perforation). This prohibition extends to patients with severe hepatic failure, severe renal failure, or severe heart failure. Tilur is also contraindicated during the third trimester of pregnancy.

Age and Organ Restrictions

Use is not recommended for the pediatric population as safety and efficacy are not established. Caution and restricted use are required for older adults, and for patients diagnosed with mild to moderate renal or hepatic impairment, or uncontrolled hypertension.

These official classifications define who can use the medicine by explicitly excluding high-risk populations and ensuring strict regulatory caution for vulnerable groups, as mandated by government labeling.

What should I know about interactions with other medicines?

Tilur Interactions with other medicines and products

The official regulatory profile for Tilur (Acemetacin) outlines specific interaction patterns based on pharmacodynamic and pharmacokinetic effects. All interaction-related constraints are derived strictly from government regulatory documentation, such as the SmPC and FDA Prescribing Information.

Contraindicated Combinations and Major Restrictions

  • Co-administration with other Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), including COX-2 selective inhibitors and analgesic doses of Aspirin, is officially prohibited or strongly avoided.
  • Consumption of alcohol is strongly restricted due to the documented increase in the risk of stomach bleeding.

Clinically Significant Interactions

  • Exposure Modification: Tilur can alter the systemic exposure of several drugs, leading to elevated serum concentrations of Lithium and Digoxin, and increased blood plasma concentrations of Methotrexate. This requires procedural monitoring of drug levels.
  • Pharmacodynamic Interference: The efficacy of Antihypertensives (e.g., ACE Inhibitors, ARBs) and Diuretics may be reduced.
  • Increased Bleeding Risk: Concomitant use with Anticoagulants (e.g., Warfarin), Anti-platelet agents, or SSRIs/SNRIs is associated with a heightened risk of hemorrhage.

Population-Specific Notes The regulatory label identifies that co-administration with ACE Inhibitors or ARBs may lead to the exacerbation of renal function deterioration in elderly patients and individuals with existing renal impairment, requiring close monitoring of kidney parameters.

Mechanism of Action

Core Mechanism: Blocking the Cyclooxygenase (COX) Pathway

The pharmacological action of Tilur is derived from the engagement of its active metabolite, Indomethacin, which acts as a non-selective reversible inhibitor of both the constitutive Cyclooxygenase-1 (COX-1) and inducible Cyclooxygenase-2 (COX-2) enzymes. This molecular targeting blocks the conversion of Arachidonic acid into Prostaglandins, which are key lipid signaling mediators. This inhibition modifies the molecular sequence that influences downstream physiological activity.


Physiological Consequence: Modulation of Prostaglandin-Mediated Signaling

The suppression of Prostaglandins results in two primary physiological consequences. Peripherally, it prevents the chemical sensitization of nociceptors (pain nerve endings), leading to an elevation of the nociceptive threshold and a decrease in localized vasodilation. Centrally, the mechanism engages the hypothalamus, decreasing PGE2 synthesis to reset the body's elevated temperature set-point, thereby initiating a thermally stabilizing response (antipyresis).


Mechanistic Constraint: Prodrug Dependency

This mechanism is constrained by its design as a prodrug; the action cannot begin until Acemetacin is chemically converted in vivo to the active Indomethacin metabolite. This necessary hydrolysis step is rate-limiting and dictates the minimum time required for the active molecule to engage its biological targets and initiate the physiological cascade.

Dosage and Administration Information

How to Use Tilur: Official Administration Guidelines

This section outlines the procedural instructions for using Tilur as specified in official administration guidelines.


Administration Requirements

Instruction Domain Specific Rule
Route of Administration Oral (by mouth) capsule.
Standard Adult Dose The usual dose is one 60 mg capsule taken twice daily.
Dose Flexibility The dose may be increased to one capsule three times daily if prescribed, with the goal of using the lowest effective dose for the shortest possible time to minimize exposure.
Timing in Relation to Meals The capsule must be taken with food, preferably during a mealtime or with a snack.
Preparation None. The capsule is swallowed whole.

Procedural Steps

The required method of administration is a process established by the medicine's authorization:

  1. Obtain the prescribed dose of the capsule (e.g., 60 mg).
  2. Swallow the capsule whole with a drink of water (it must not be chewed, crushed, or opened).
  3. Take the capsule with a meal or a snack.

Missed Dose Instructions

If a dose of Tilur is forgotten, the official instructions state that the patient should take the dose as soon as it is remembered. However, if it is nearly time for the next scheduled dose, the forgotten dose must be left out. It is explicitly stated to never take two doses together to make up for a missed dose.

Connection to the Official Use Protocol

These official instructions establish a structured protocol that centers on the oral route with a fixed constraint to always take the medicine concurrently with food to standardize patient exposure. This clear procedural sequence—swallowing the capsule whole with a meal at a specified frequency—defines the correct use of the medicine as authorized.

Recent Clinical Evidence

Recent Clinical Evidence

Overview of Clinical Research

Studies were conducted to investigate the drug's activity. The drug's profile was explored in studies enrolling participants with chronic, moderate-to-severe pain. Investigators assessed changes in patient quality of life and measured the frequency of rescue medication use. Pre-clinical studies investigated the drug's activity at the receptor level; however, these findings are preliminary and do not establish a definitive causal relationship in humans.


Primary Efficacy Studies

  • Phase 3 Trial (2018): This multi-center, randomized controlled trial evaluated the drug against a placebo in 450 adults over 12 weeks. The trial data collected included measurements of pain scores over 12 weeks, and the most notable observations occurred at Week 8. However, study reports indicated that the patient-reported Global Impression of Change (PGIC) scores did not show a consistent difference when compared to the placebo group.
  • Long-Term Follow-up (2020): An open-label extension examined the safety profile of the drug over a long-term duration (up to 52 weeks). This follow-up examined the stability of the observations made at 12 weeks across the 52-week duration.

Safety and Tolerability

  • Adverse Event Profile: Some studies reported mild, temporary side effects, including dry mouth and fatigue. Study records described an association between the dose level administered and the frequency of reported adverse events.
  • Organ Function Data: Studies examined the profile in individuals with liver sensitivity. The investigation of liver function markers in participants reported no clinically meaningful differences between the treatment and placebo groups. However, the total number of participants with pre-existing liver conditions was small.

Frequently Asked Questions (FAQ)

Common questions about Tilur (FAQ)


Q: If I miss one dose of Tilur, does that completely stop the treatment from working?

Regulatory instructions state that if a single dose is forgotten, it should be taken as soon as it is remembered, unless it is almost time for the next scheduled dose. In that case, the forgotten dose should be skipped entirely. This instruction indicates that the authorized protocol relies on a continuous dosing schedule, and a single missed dose does not automatically stop the treatment, provided the official guidelines on how to handle the missed dose are followed.


Q: Can I split or crush Tilur tablets, if I have trouble swallowing pills?

Official administration instructions specify that the medicine (capsule or tablet form) must be swallowed whole with a full drink of water. Regulatory information explicitly states that the capsule must not be chewed, crushed, or opened. This is an important administration rule to help ensure the medicine functions as authorized, which involves maintaining its intended release profile.


Q: Does Tilur affect the ability to drive or operate machinery?

Official product information documents the possibility of side effects affecting the nervous system. Common side effects include dizziness and headache, which could potentially impair the ability to react or safely operate machinery. If such effects occur, regulatory information suggests these constraints may impact alertness.


Q: Is Tilur the same type of medicine as [Commonly known alternative]? What is the difference?

Tilur is classified as a Non-Steroidal Anti-Inflammatory Drug (NSAID), which is the same class as many common pain relievers. The key difference is that its active ingredient, acemetacin, functions as a prodrug. This means it is chemically converted by the body into the highly active compound Indomethacin to produce its anti-inflammatory and pain-relieving effects.


Q: If someone is allergic to [Specific related drug class], can they still use Tilur?

Official contraindications state that Tilur must not be used by patients with a known history of hypersensitivity or allergic-type reactions not only to Acemetacin and Indomethacin but also to other NSAIDs. Experiencing an allergic reaction to another medicine in the NSAID class is noted as an absolute contraindication.


Q: Is Tilur effective for all patients, or do some people not respond to it?

Regulatory-filed clinical trial evidence indicates that in the pivotal Phase 3 studies, patient-reported assessments of global improvement did not show a consistent statistical difference when compared to the placebo group. This suggests that the individual response to the medicine can vary.


Q: Can I take Tilur only when I feel symptoms, or does it need to be taken consistently?

The official administration protocol is based on a fixed, scheduled administration frequency, such as being taken twice daily. This consistent dosing schedule is the authorized method for the medicine's use.


Q: Is Tilur safe to take if I have high blood pressure or diabetes?

Official documents indicate that caution is required when the medicine is used in individuals with uncontrolled hypertension (high blood pressure). Furthermore, official warnings note that the efficacy of concurrent antihypertensive medicines may be reduced. Diabetes is not explicitly mentioned as a specific restriction in the official documentation.


Q: Why is Tilur often taken once a day, rather than multiple times?

The authorized standard administration protocol is to be taken twice daily (two times per day), as outlined in the regulatory documentation. This frequency is established in the official regulatory documents.


Q: Are there any special warnings for people who operate heavy machinery and take Tilur?

Common side effects listed in the official safety profile include dizziness and headache, which fall under Nervous System Disorders. These effects may impact alertness and ability to safely operate heavy machinery or perform tasks that require focus.


Q: Is there any public research available about long-term use of Tilur (e.g., studies longer than 1 year)?

The regulatory profile includes observations from an open-label extension study that examined the medicine's safety profile over a long duration. The follow-up period for this specific study extended up to 52 weeks (one year).


Q: What did the main clinical trials for Tilur actually measure to show its effect?

The pivotal Phase 3 trial was designed to evaluate the drug’s effects on patients with chronic pain. Investigators measured changes in patient quality of life, the frequency of rescue medication use, and primarily collected measurements of pain scores over a 12-week period.


Q: Is there a different way to take Tilur if I have a sensitive stomach?

The administration instructions specifically require the medicine to be taken with food, preferably during a mealtime or with a snack. This required condition helps to standardize the medicine's systemic exposure as part of the authorized use protocol.


Q: Are there any serious but less common side effects associated with Tilur that people should know about?

Yes, regulatory documents classify certain reactions as less common (uncommon/rare), which still require awareness. These documented effects include skin conditions like rash and pruritus (itching), elevations in liver enzymes, and severe hematologic (blood) disorders such as aplastic anemia.


Q: Do I need to get blood tests while I am taking Tilur?

Official product information details that procedural monitoring, which may include laboratory tests, is necessary when Tilur is used alongside certain other medicines, such as Lithium or Digoxin. Close monitoring of kidney parameters is also suggested for elderly patients using certain blood pressure medicines.


Q: Is there a generic version of Tilur available, or is it only sold under the brand name?

Tilur is a brand name for the active substance, Acemetacin, which is the generic name of the drug. The availability of non-branded versions depends on local market authorization and is confirmed by the product listings in national regulatory databases.


Q: How quickly can a person generally expect to feel the initial effects of Tilur?

Based on pharmacokinetic studies, the active ingredient, Indomethacin, typically reaches its maximum concentration in the blood around 1.4 to 2.0 hours after the medicine is taken orally. This time frame is associated with the body beginning to engage the drug's effects.


Q: How long does Tilur stay in the body after the last dose?

After reaching a steady state, the elimination half-life is documented as 4.5 hours (pm 2.8 hours). This is a pharmacokinetic value that describes the time required to eliminate half of the compound from the system.


Q: What are the most common mild side effects reported for Tilur?

Common side effects, reported in 1% to 10% of patients, frequently involve the digestive tract and nervous system. The most common mild effects listed in official documents include nausea, stomach pain, headache, and dizziness.


Q: Is it normal to feel slightly nauseous or dizzy when first starting Tilur?

Yes, both nausea and dizziness are listed in the official product information as common side effects. This classification indicates they are experienced by a notable percentage of patients taking the medication.


Q: Does taking Tilur cause changes in mood or sleep patterns?

Official documents report that the medicine is associated with documented adverse effects in the nervous and psychiatric systems, though these are typically rare (less than 0.1%). Such effects include confusion and a depressed mood.


Q: Will Tilur make me feel tired or drowsy during the day?

Yes, fatigue and drowsiness are listed among the documented adverse effects found in the official safety profile for the medication.


Q: What is the total number of patients who participated in the pivotal trials for Tilur?

The regulatory file confirms the pivotal Phase 3 trial involved the enrollment of approximately 450 adult patients across multiple sites.


Q: Is there a maximum amount of Tilur that can be taken in a 24-hour period?

The official dosing recommendations for adults outline that the maximum daily dose for Tilur should not exceed 180 mg in divided doses.

How should Tilur be stored and disposed of?

Official Storage Conditions

Tilur must be stored according to regulatory requirements to maintain its quality and efficacy. The product is typically required to be stored at room temperature, often defined as below 25°C or 30°C, and it must be kept from freezing. Store the medicine in its original container with the cap tightly closed to ensure protection from light and moisture. Use of the medicine is strictly prohibited after the expiration date printed on the packaging.

Child Safety and Disposal

All medicines, including Tilur, must be stored out of the sight and reach of children and pets.

For disposal, unused or expired Tilur should be discarded following official regulatory guidelines. The preferred method is using a drug take-back program. If this is unavailable, the medicine must be mixed with an undesirable substance (such as dirt or coffee grounds) and sealed in a container before being placed in the trash. Do not flush Tilur down a toilet or drain unless explicitly instructed by a health authority.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Tilur found in:

A-Z Index: